Skip to main content

Together we are beating cancer

Donate now

Science & Technology | News

Read news articles in our Science & Technology section
Showing 12 out of 356 results
An image of a radiotherapy machine. Its lights are glowing blue.

Our PLATO-ACT4 clinical trial has found a kinder and more targeted way of using radiotherapy to treat early-stage anal cancer. Our PLATO-ACT4 clinical trial has found a kinder and more targeted way of using radiotherapy to treat early-stage anal cancer.

by Amal Iman | News | 1 July 2025

1 July 2025

This entry is part 5 of 5 in the series Stand Up To Cancer
A group of killer T cells (green and red) surrounding a cancer cell (blue, center).

With the world's cancer researchers in Chicago for the 2025 American Society of Clinical Oncology (ASCO) annual meeting, we're highlighting some of the most interesting and important studies. With the world's cancer researchers in Chicago for the 2025 American Society of Clinical Oncology (ASCO) annual meeting, we're highlighting some of the most interesting and important studies.

by Tim Gunn, Amal Iman | News | 31 May 2025

31 May 2025

A breast cancer cell seen through an electron microscope.

Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery

by Amal Iman, Tim Gunn | News | 13 May 2025

13 May 2025

Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A team of our Cancer Grand Challenges researchers have found the first specific clue about what could be behind the rise of bowel cancer in under-50s. A team of our Cancer Grand Challenges researchers have found the first specific clue about what could be behind the rise of bowel cancer in under-50s.

by Tim Gunn | News | 23 April 2025

23 April 2025

A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025

Researchers discussing work in lab

Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer.

by Fiona Scott | News | 31 March 2025

31 March 2025

Lung cancer cells seen through a microscope, in shades of purple and green,

Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer. Cancer Grand Challenges is offering up to £20m funding to teams that can answer seven of the biggest and most important questions in cancer.

by Tim Gunn | News | 5 March 2025

5 March 2025

Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

Data centre filled with rows of servers

Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk. Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk.

by Amy Warnock, Graeme Sneddon | News | 22 January 2025

22 January 2025

A concept illustration of the tumour microenvironment

A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers. A bold change of approach by our scientists investigating what prevents immunotherapy from working in a large number of patients has led to a significant discovery that could improve outcomes across multiple cancers.

by Elisa Mitchell | News | 7 January 2025

7 January 2025